» Articles » PMID: 17573945

Oral Branched-chain Amino Acid Supplementation Improves the Oxidized/reduced Albumin Ratio in Patients with Liver Cirrhosis

Overview
Journal Hepatol Res
Specialty Gastroenterology
Date 2007 Jun 19
PMID 17573945
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Branched-chain amino acid (BCAA) supplementation improves hypoalbuminemia in decompensated cirrhotics. Recently, it was clarified that the ratio of oxidized albumin within total albumin rises with progression of liver cirrhosis. We conducted a feasibility study to investigate whether BCAA supplementation might improve this ratio.

Methods: Seven cirrhotic patients (age: 70 +/-> 6 years; M/F = 4/3; etiology: hepatitis C in six and non-B/non-C hepatitis virus in one; Child-Pugh classification: A in six and B in one) were enrolled consecutively in this study in October 2004 to March 2005. Patients were given 4 g BCAA after each meal for 8 weeks. Serum total, oxidized and reduced albumin, plasma amino acids, glutathione, zinc, selenium, and lipid peroxide concentrations were measured every 2 weeks.

Results: Low total albumin, high oxidized albumin, and low reduced albumin levels were observed at entry. After 8 weeksBCAA supplementation, the ratio of oxidized albumin within total albumin decreased significantly and that of reduced albumin increased significantly (P < 0.05, respectively). Total albumin tended to rise and lipid peroxide concentrations tended to fall, but not significantly.

Conclusion: BCAA supplementation improved the oxidized/reduced state of serum albumin. This intervention is effective to maintain the quality of serum albumin in cirrhotic patients.

Citing Articles

Effect of perioperative branched chain amino acids supplementation in liver cancer patients undergoing surgical intervention: A systematic review.

Yap K, Chi H, Ng S, Ng D, Shelat V World J Gastrointest Surg. 2023; 15(11):2596-2618.

PMID: 38111761 PMC: 10725538. DOI: 10.4240/wjgs.v15.i11.2596.


Use of Branched-Chain Amino Acids as a Potential Treatment for Improving Nutrition-Related Outcomes in Advanced Chronic Liver Disease.

Colosimo S, Bertoli S, Saffioti F Nutrients. 2023; 15(19).

PMID: 37836474 PMC: 10574343. DOI: 10.3390/nu15194190.


Effect of dietary branched chain amino acids on liver related mortality: Results from a large cohort of North American patients with advanced HCV infection.

Yu L, Paski S, Dodge J, Bambha K, Biggins S, Ioannou G PLoS One. 2023; 18(4):e0284739.

PMID: 37098004 PMC: 10128927. DOI: 10.1371/journal.pone.0284739.


Effects of Rifaximin on Circulating Albumin Structures and Serum Ammonia Levels in Patients with Liver Cirrhosis: A Preliminary Study.

Miwa T, Hanai T, Imai K, Takai K, Shiraki M, Hayashi H J Clin Med. 2022; 11(24).

PMID: 36555935 PMC: 9784744. DOI: 10.3390/jcm11247318.


Serum Albumin Redox States: More Than Oxidative Stress Biomarker.

Tabata F, Wada Y, Kawakami S, Miyaji K Antioxidants (Basel). 2021; 10(4).

PMID: 33804859 PMC: 8063786. DOI: 10.3390/antiox10040503.